Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia

OBJECTIVES: To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumonia. DESIGN: Cohort study. SETTING: Thirteen hospitals in New Jersey, United States during March to June 2020. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Ronaldo C., Shah, Roshan, Nyirenda, Themba, Oe, Yukiko, Sarfraz, Khurram, Panthappattu, Justin J., Philip, Lesley, Bheeman, Chandni, Shah, Neel, Shah, Sapan, Dar, Sophia, Hung, Sung, Rahman, Waqas, Im, Hyun, Marafelias, Michael, Omidvari, Karan, Pradhan, Anuja, Sadikot, Sean, Rose, Keith M., Sperber, Steven J., Josephs, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291358/
https://www.ncbi.nlm.nih.gov/pubmed/34291223
http://dx.doi.org/10.1097/CCE.0000000000000493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291358/
https://www.ncbi.nlm.nih.gov/pubmed/34291223
http://dx.doi.org/10.1097/CCE.0000000000000493

Ejemplares similares